Potassium iodide and Malignant neoplasm progression - a phase IV clinical study of FDA data

Summary:

Malignant neoplasm progression is reported as a side effect among people who take Potassium iodide (potassium iodide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Potassium iodide. It is created by eHealthMe based on reports of 1,847 people who have side effects when taking Potassium iodide from the FDA, and is updated regularly.

What is Potassium iodide?

Potassium iodide has active ingredients of potassium iodide. It is often used in thyroid diseases. eHealthMe is studying from 1,919 Potassium iodide users. Check the latest studies of Potassium iodide.

What is Malignant neoplasm progression?

Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,514 drugs and 1,634 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.

On Jul, 18, 2026

1,847 people reported to have side effects when taking Potassium iodide.
Among them, 26 people (1.41%) have Malignant neoplasm progression.

Could Potassium iodide cause Malignant neoplasm progression?

Among these 26 people:

How long have people been on Potassium iodide when they have Malignant neoplasm progression? *

What is the gender of people who have Malignant neoplasm progression when taking Potassium iodide? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Malignant neoplasm progression when taking Potassium iodide? *

What are other drugs people take besides Potassium iodide? *

What are other side effects people have besides Malignant neoplasm progression? *

Nausea (feeling of having an urge to vomit): 19 people, 73.08%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 46.15%
Thrombocytopenia (decrease of platelets in blood): 10 people, 38.46%
Fatigue (feeling of tiredness): 10 people, 38.46%
Breast Cancer Metastatic: 8 people, 30.77%
Dyspnea (difficult or laboured breathing): 8 people, 30.77%
Transaminases Increased: 7 people, 26.92%
Hyperhidrosis (abnormally increased sweating): 7 people, 26.92%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 26.92%
Joint Pain: 4 people, 15.38%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 11 people, 42.31%
Breast Cancer Metastatic: 11 people, 42.31%
Migraine (headache): 8 people, 30.77%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 30.77%
High Blood Pressure: 8 people, 30.77%
Thyroiditis (inflammation of thyroid gland): 1 person, 3.85%
Neuroblastoma (a cancer that forms in your nerve tissue): 1 person, 3.85%
Neoplasm Recurrence (reoccurrence of tumour): 1 person, 3.85%
Nausea (feeling of having an urge to vomit): 1 person, 3.85%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium iodide and have Malignant neoplasm progression?

- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Potassium iodide:

Potassium iodide (1,919 reports)

Browse all side effects of Potassium iodide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,514 drugs)

Browse all the conditions that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,634 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium iodide (the active ingredients of Potassium iodide) and Potassium iodide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.